Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sphere of biopharmaceuticals, presenting promising enhancements throughout various health care and industrial applications. With its structural similarity to naturally derived human serum albumin, OsrHSA gives a safer, much more trusted alternate for therapeutic